These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 11850774)

  • 1. Telomerase is not an oncogene.
    Harley CB
    Oncogene; 2002 Jan; 21(4):494-502. PubMed ID: 11850774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomerase and human tumorigenesis.
    Stewart SA; Weinberg RA
    Semin Cancer Biol; 2000 Dec; 10(6):399-406. PubMed ID: 11170862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telomerase: regulation, function and transformation.
    Dong CK; Masutomi K; Hahn WC
    Crit Rev Oncol Hematol; 2005 May; 54(2):85-93. PubMed ID: 15843091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Senescence and immortalization: role of telomeres and telomerase.
    Shay JW; Wright WE
    Carcinogenesis; 2005 May; 26(5):867-74. PubMed ID: 15471900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of telomerase to create bioengineered tissues.
    Shay JW; Wright WE
    Ann N Y Acad Sci; 2005 Dec; 1057():479-91. PubMed ID: 16399914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Events in the immortalizing process of primary human mammary epithelial cells by the catalytic subunit of human telomerase.
    Kim H; Farris J; Christman SA; Kong BW; Foster LK; O'Grady SM; Foster DN
    Biochem J; 2002 Aug; 365(Pt 3):765-72. PubMed ID: 11978176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of p53 combined with expression of the catalytic subunit of telomerase is sufficient to immortalize primary human ovarian surface epithelial cells.
    Yang G; Rosen DG; Mercado-Uribe I; Colacino JA; Mills GB; Bast RC; Zhou C; Liu J
    Carcinogenesis; 2007 Jan; 28(1):174-82. PubMed ID: 16829690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomerase inhibition in a mouse cell line with long telomeres leads to rapid telomerase reactivation.
    Marie-Egyptienne DT; Brault ME; Zhu S; Autexier C
    Exp Cell Res; 2008 Feb; 314(3):668-75. PubMed ID: 18067891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular senescence and cancer.
    Wynford-Thomas D
    J Pathol; 1999 Jan; 187(1):100-11. PubMed ID: 10341711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retroviral-mediated expression of telomerase in normal human cells provides a selective growth advantage.
    Forsythe HL; Elmore LW; Jensen KO; Landon MR; Holt SE
    Int J Oncol; 2002 Jun; 20(6):1137-43. PubMed ID: 12011990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological intervention strategies for affecting telomerase activity: future prospects to treat cancer and degenerative disease.
    Tárkányi I; Aradi J
    Biochimie; 2008 Jan; 90(1):156-72. PubMed ID: 17945408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Balancing instability: dual roles for telomerase and telomere dysfunction in tumorigenesis.
    Hackett JA; Greider CW
    Oncogene; 2002 Jan; 21(4):619-26. PubMed ID: 11850787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomerase: cellular immortalization and neoplastic transformation. Multiple functions of a multifaceted complex.
    Belgiovine C; Chiodi I; Mondello C
    Cytogenet Genome Res; 2008; 122(3-4):255-62. PubMed ID: 19188694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional regulation of the telomerase hTERT gene as a target for cellular and viral oncogenic mechanisms.
    Horikawa I; Barrett JC
    Carcinogenesis; 2003 Jul; 24(7):1167-76. PubMed ID: 12807729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reconstitution of human telomerase reverse transcriptase expression rescues colorectal carcinoma cells from in vitro senescence: evidence against immortality as a constitutive trait of tumor cells.
    Dalerba P; Guiducci C; Poliani PL; Cifola I; Parenza M; Frattini M; Gallino G; Carnevali I; Di Giulio I; Andreola S; Lombardo C; Rivoltini L; Schweighoffer T; Belli F; Colombo MP; Parmiani G; Castelli C
    Cancer Res; 2005 Mar; 65(6):2321-9. PubMed ID: 15781646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomerase and telomere stability: a new class of tumor suppressor?
    Elmore LW; Holt SE
    Mol Carcinog; 2000 May; 28(1):1-4. PubMed ID: 10820482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomere lengthening in telomerase-negative cells: the ends are coming together.
    Scheel C; Poremba C
    Virchows Arch; 2002 Jun; 440(6):573-82. PubMed ID: 12070595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical implications of telomerase in cancer.
    Kim NW
    Eur J Cancer; 1997 Apr; 33(5):781-6. PubMed ID: 9282117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular senescence in vivo: a barrier to tumorigenesis.
    Prieur A; Peeper DS
    Curr Opin Cell Biol; 2008 Apr; 20(2):150-5. PubMed ID: 18353625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telomerase-immortalized sheep fibroblasts can be reprogrammed by nuclear transfer to undergo early development.
    Cui W; Wylie D; Aslam S; Dinnyes A; King T; Wilmut I; Clark AJ
    Biol Reprod; 2003 Jul; 69(1):15-21. PubMed ID: 12606403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.